Keywords: long-term, efficacy, ciba, visudyne, pivotal, trial, vision

Long-term efficacy with CIBA's Visudyne

Article | 29 March 2000

Print This

A pivotal trial of CIBA Vision and QLT PhotoTherapeutics' Visudyne(verteporfin) has demonstrated the safety and efficacy of the compound ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in